NovoCare vs LillyDirect: 2026 Cash-Pay Price Comparison
Key Takeaways
- NovoCare (Novo Nordisk) handles Wegovy — injection pen from $349/month, pill from $149/month
- LillyDirect (Eli Lilly) handles Zepbound — vials/KwikPen from $299/month, $449/month at maintenance
- Both are manufacturer-direct, authentic brand-name products with no middleman markup
- NovoCare wins on entry price ($149 pill vs. $299 Zepbound starter)
- LillyDirect has a 45-day refill rule — miss it and your price jumps up to $699/month
NovoCare and LillyDirect are manufacturer-direct pharmacy platforms from the two largest GLP-1 drug makers. They're not competing on the same products — NovoCare sells Wegovy (semaglutide), and LillyDirect sells Zepbound (tirzepatide) — but they're absolutely competing for your prescription dollars.
If you're paying cash for a GLP-1 and trying to decide between semaglutide and tirzepatide, the cost comparison between these two platforms is one of the most important pricing decisions you'll make.
Head-to-Head Pricing
| Category | NovoCare (Wegovy) | LillyDirect (Zepbound) |
|---|---|---|
| Company | Novo Nordisk | Eli Lilly |
| Active ingredient | Semaglutide | Tirzepatide |
| Cheapest entry point | $149/mo (pill) | $299/mo (vial/KwikPen) |
| Injection starter dose | $199/mo intro* | $299/mo |
| Injection maintenance | $349/mo | $449/mo |
| High dose | $399/mo (7.2 mg HD) | $449/mo (15 mg) |
| Oral option? | Yes — Wegovy pill | No (Foundayo is separate) |
| Delivery format | Pre-filled pen (inj) / tablet (oral) | Single-dose vial or KwikPen |
| Refill rules | None — order when ready | 45-day window for $449 pricing |
| Subscription discount? | Yes — $329/mo (3-month) | Built into Journey Program |
| Walmart pickup? | No | Yes |
| Free shipping? | Yes | Yes |
*NovoCare $199 intro for first 2 months on 0.25 mg or 0.5 mg, through August 31, 2026. LillyDirect 45-day rule: miss the refill window on 7.5 mg+ and price jumps to $499–$699.
12-Month Cost Projection
GLP-1 treatment involves dose escalation over the first several months. Here's what a typical year looks like at each platform:
| Month | NovoCare — Pen | NovoCare — Pill | LillyDirect |
|---|---|---|---|
| Month 1 (starter) | $199 | $149 | $299 |
| Month 2 | $199 | $149 | $399 |
| Month 3 | $349 | $149–$199 | $449 |
| Months 4–12 (maint.) | $349/mo | $299/mo | $449/mo |
| 12-Month Total | $3,892 | ~$3,190 | ~$5,039 |
Estimates assume standard titration timelines. NovoCare pill assumes 2 months at $149, 1 month at $199, then 9 months at $299. LillyDirect assumes $299/$399 for first 2 months, $449 for 10 months.
Over a full year, NovoCare's Wegovy pill saves approximately $1,850 compared to LillyDirect's Zepbound. Even the Wegovy pen saves about $1,150/year over Zepbound. The question is whether tirzepatide's dual-mechanism (GIP + GLP-1) and potentially higher weight loss (~5–7% more in trials) justifies the price premium for your situation.
Platform Experience Comparison
NovoCare Strengths
- Lower prices across the board — especially the $149 pill entry
- Two format options — pen or pill, same platform
- No refill pressure — order when you're ready, no penalty for delays
- Subscription pricing available through telehealth partners (Ro, WeightWatchers, LifeMD, Hims, Sesame)
LillyDirect Strengths
- Walmart pharmacy pickup — same-day access at participating locations
- Tirzepatide's clinical profile — dual GIP/GLP-1 mechanism, higher average weight loss
- Flat $449 cap at all maintenance doses (7.5–15 mg) — no price increase at higher strengths
- KwikPen now available — no syringe draw-up required (multi-dose pen format)
Which Should You Choose?
Choose NovoCare (Wegovy) if: Budget is your top priority. The pill at $149/month is the cheapest brand-name GLP-1 on the market. Even the injection pen at $349/month undercuts LillyDirect by $100/month.
Choose LillyDirect (Zepbound) if: Maximum weight loss is your priority and you can afford $449/month. Clinical data suggests tirzepatide produces more weight loss than semaglutide on average, and LillyDirect's flat $449 cap at all maintenance doses means no price surprises as you titrate up.
Choose compounded if: Cost is the dominant factor and you're comfortable with a non-FDA-approved formulation. Compounded semaglutide from $99/month and compounded tirzepatide from $133/month undercut both manufacturer platforms significantly.
Injectable semaglutide
Compounded medications are prepared by pharmacies and are not FDA-approved. They have not been evaluated for safety, efficacy, or manufacturing quality by the FDA.
Check Current Pricing →Paid link · We may earn a commission
Injectable
Compounded medications are prepared by pharmacies and are not FDA-approved. They have not been evaluated for safety, efficacy, or manufacturing quality by the FDA.
Check Current Pricing →Paid link · We may earn a commission
NovoCare wins on price. LillyDirect wins on clinical potency. Both are legitimate, manufacturer-direct platforms selling authentic brand-name medications. If you're choosing between them purely on cost, the Wegovy pill via NovoCare at $149–$299/month is the better deal by a wide margin.
Prices verified as of July 15, 2026 via manufacturer websites and reporting. Always confirm current pricing with NovoCare or LillyDirect before starting treatment.